<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03831035</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL17_0387</org_study_id>
    <nct_id>NCT03831035</nct_id>
  </id_info>
  <brief_title>Fast Exome for Diagnosis of Congenital Conditions in Infants Under 12 Months of Age Hospitalized in Intensive Care Unit</brief_title>
  <acronym>REUNIR</acronym>
  <official_title>Fast Exome for Diagnosis of Congenital Conditions in Infants Under 12 Months of Age Hospitalized in Intensive Care Unit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      An early diagnosis of congenital malformations and suspected genetic conditions in critically
      ill infants is essential to perform specific adapted care, prevention, and give proper
      genetic counseling. However, etiologies are various and each of them is individually very
      rare. Thanks to next-generation sequencing technologies, diagnosis time frames have
      drastically decreased and the investigators have observed an increase in diagnosis yields.

      This study aims to evaluate the feasibility of fast trio exome sequencing (less than 16 days
      between informed consent signature and the consultation for results to the parents) in
      infants under the age of 12 months hospitalized in Intensive Care Unit (ICU).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This prospective study is the first French study aiming to evaluate the feasibility of fast
      trio exome sequencing (less than 16 days between informed consent signature and consultation
      for results presentation to the parents) in 15 infants under the age of 12 months
      hospitalized in the Intensive Care Unit. Included patients will have a year of follow-up
      examination.

      The main evaluation criterion is the yield of exome results given to the family before 16
      days. The secondary evaluation criteria are 1/ duration of each step until the results 2/
      diagnosis yield : identification of the etiology 3/ adjustment of medical care allowed by the
      exome diagnosis 4/quantity of blood necessary to achieve diagnosis 5/ duration of hospital
      stay and number of medical consultations in the year following inclusion.

      Exome sequencing will be performed on top of classical analysis ordinarily prescribed.
      Medical care will not be modified until exome results reception. After signature of informed
      consent, blood samples of the infant and both parents will be used for trio exome sequencing,
      which includes 3 steps : the analytical step (blood sample DNA extraction and high-throughput
      sequencing), the bioinformatic step, and the interpretation step.

      The study includes four medical consultations:

      1/consultation with a geneticist for inclusion, 2/consultation with a geneticist to give the
      exome results, 3/ consultation at 3 months after the results for the sanger-confirmation of
      the exome result, 4/ consultation at one year after the inclusion for medical follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 8, 2019</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Yield of exome results given to the family before 16 days</measure>
    <time_frame>16 days maximum after inclusion</time_frame>
    <description>number of days between the collect sample and results</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of each step until the results (the analytical step, the bioinformatic step, the interpretation step).</measure>
    <time_frame>16 days maximum after inclusion</time_frame>
    <description>number of days between the collect sample and results</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diagnosis yield : identification of the etiology</measure>
    <time_frame>3 months</time_frame>
    <description>number of days between the collect sample and diagnostic confirmation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adjustment of medical care allowed by the exome diagnosis</measure>
    <time_frame>16 days maximum after inclusion</time_frame>
    <description>Any additions or deletions of a diagnostic exam, medical care specific to the diagnosed pathology or screening of a known complication</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantity of blood necessary to achieve diagnosis</measure>
    <time_frame>16 days maximum after inclusion</time_frame>
    <description>blood volume necessary to achieve diagnosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantity of blood necessary to achieve diagnosis</measure>
    <time_frame>16 days maximum after inclusion</time_frame>
    <description>number of samples necessary to achieve diagnosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>duration of hospital stay in the year following inclusion</measure>
    <time_frame>a year after inclusion</time_frame>
    <description>number of days of hospital stay in the year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of medical consultations in the year following inclusion</measure>
    <time_frame>a year after inclusion</time_frame>
    <description>number of medical consultations in the year</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Infant, Newborn, Diseases</condition>
  <condition>Congenital Malformations</condition>
  <condition>Intensive Care Unit</condition>
  <condition>Neurologic Symptoms</condition>
  <arm_group>
    <arm_group_label>15 patients and both parents.</arm_group_label>
    <description>The patients are aged 12 months or under hospitalized in the ICU suffering from multiple congenital malformations and/or neurologic symptoms.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Genetic analyse by whole exome sequencing</intervention_name>
    <description>Exome sequencing requires analytic, bio informatic and interpretation steps.</description>
    <arm_group_label>15 patients and both parents.</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      It is a trio exome sequencing which includes 3 steps : the analytical step (blood sample DNA
      extraction and high-throughput sequencing), the bioinformatic step, and the interpretation
      step.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        This study includes 15 patients and both parents. The patients are aged 12 months or under
        hospitalized in the ICU suffering from multiple congenital malformations and/or neurologic
        symptoms
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infant aged under 12 months , hospitalized in the ICU.

          -  Infant with multiple congenital malformations or neurological symptoms for which a
             genetic origin is suspected but undiagnosed genetically.

          -  Infant for whom both biological parents have given consent for the study, genetic
             analysis for themselves anf their child.

          -  Infant and parents registered in the French National health service

        Exclusion Criteria:

          -  Absence of one or both parental sample.

          -  Precise genetic diagnosis made pre- or post-natally with chromosomal (I.e : Down
             syndrome), Sanger (i.e : infantile spinal amyotrophia) methylation (i.e : Prader-Willi
             syndrome) or triplet amplification (I.e : neonatal Steinert myotonia) studies.

          -  Strong clinical evidence for a with chromosomal (I.e : Down syndrome), Sanger (i.e :
             infantile spinal amyotrophia) methylation (i.e : Prader-Willi syndrome) or triplet
             amplification (I.e : neonatal Steinert myotonia) studies.

          -  Impossibility for one or both parents to give his or her consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>12 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marjolaine WILLEMS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical genetics Arnaud de Villeneuve</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marjolaine WILLEMS, MD</last_name>
    <phone>+33467336564</phone>
    <email>m-willems@chu-montpellier.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mouna BARAT, PharmD, PhD</last_name>
    <phone>0467336152</phone>
    <email>mouna.barat@inserm.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical genetics Arnaud de Villeneuve</name>
      <address>
        <city>Montpellier</city>
        <state>Hérault</state>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marjolaine WILLEMS, MD</last_name>
      <phone>+33467336564</phone>
      <email>m-willems@chu-montpellier.fr</email>
    </contact>
    <contact_backup>
      <last_name>Mouna BARAT, PhD</last_name>
      <phone>0467336152</phone>
      <email>mouna.barat@inserm.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Açikalin A, Bağir EK, Torun G, Ateş BT, Erdoğan S, Uğuz A, Ergın M, Büyükkurt S, Ozgünen FT, Tunali N, Gümürdülü D. Perinatal autopsy evaluation of 2150 autopsies in the Çukurova region of Turkey. Turk Patoloji Derg. 2014;30(3):189-94. doi: 10.5146/tjpath.2014.01266.</citation>
    <PMID>24994614</PMID>
  </reference>
  <reference>
    <citation>Baird PA, Anderson TW, Newcombe HB, Lowry RB. Genetic disorders in children and young adults: a population study. Am J Hum Genet. 1988 May;42(5):677-93.</citation>
    <PMID>3358420</PMID>
  </reference>
  <reference>
    <citation>Bonnet D. [Genetics of congenital heart diseases]. Presse Med. 2017 Jun;46(6 Pt 1):612-619. doi: 10.1016/j.lpm.2017.05.014. Epub 2017 Jun 2. Review. French.</citation>
    <PMID>28583745</PMID>
  </reference>
  <reference>
    <citation>Dhiman V. Molecular Genetics of Epilepsy: A Clinician's Perspective. Ann Indian Acad Neurol. 2017 Apr-Jun;20(2):96-102. doi: 10.4103/aian.AIAN_447_16. Review.</citation>
    <PMID>28615892</PMID>
  </reference>
  <reference>
    <citation>Grandemange S, Sanchez E, Louis-Plence P, Tran Mau-Them F, Bessis D, Coubes C, Frouin E, Seyger M, Girard M, Puechberty J, Costes V, Rodière M, Carbasse A, Jeziorski E, Portales P, Sarrabay G, Mondain M, Jorgensen C, Apparailly F, Hoppenreijs E, Touitou I, Geneviève D. A new autoinflammatory and autoimmune syndrome associated with NLRP1 mutations: NAIAD (NLRP1-associated autoinflammation with arthritis and dyskeratosis). Ann Rheum Dis. 2017 Jul;76(7):1191-1198. doi: 10.1136/annrheumdis-2016-210021. Epub 2016 Dec 13.</citation>
    <PMID>27965258</PMID>
  </reference>
  <reference>
    <citation>Hack M, Taylor HG, Drotar D, Schluchter M, Cartar L, Andreias L, Wilson-Costello D, Klein N. Chronic conditions, functional limitations, and special health care needs of school-aged children born with extremely low-birth-weight in the 1990s. JAMA. 2005 Jul 20;294(3):318-25.</citation>
    <PMID>16030276</PMID>
  </reference>
  <reference>
    <citation>McCandless SE, Brunger JW, Cassidy SB. The burden of genetic disease on inpatient care in a children's hospital. Am J Hum Genet. 2004 Jan;74(1):121-7. Epub 2003 Dec 12. Erratum in: Am J Hum Genet. 2004 Apr;74(4):788.</citation>
    <PMID>14681831</PMID>
  </reference>
  <reference>
    <citation>Musante L, Ropers HH. Genetics of recessive cognitive disorders. Trends Genet. 2014 Jan;30(1):32-9. doi: 10.1016/j.tig.2013.09.008. Epub 2013 Oct 28. Review.</citation>
    <PMID>24176302</PMID>
  </reference>
  <reference>
    <citation>Pabinger S, Dander A, Fischer M, Snajder R, Sperk M, Efremova M, Krabichler B, Speicher MR, Zschocke J, Trajanoski Z. A survey of tools for variant analysis of next-generation genome sequencing data. Brief Bioinform. 2014 Mar;15(2):256-78. doi: 10.1093/bib/bbs086. Epub 2013 Jan 21.</citation>
    <PMID>23341494</PMID>
  </reference>
  <reference>
    <citation>Packer JS, Maxwell EK, O'Dushlaine C, Lopez AE, Dewey FE, Chernomorsky R, Baras A, Overton JD, Habegger L, Reid JG. CLAMMS: a scalable algorithm for calling common and rare copy number variants from exome sequencing data. Bioinformatics. 2016 Jan 1;32(1):133-5. doi: 10.1093/bioinformatics/btv547. Epub 2015 Sep 17.</citation>
    <PMID>26382196</PMID>
  </reference>
  <reference>
    <citation>Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.</citation>
    <PMID>25741868</PMID>
  </reference>
  <reference>
    <citation>Van der Auwera GA, Carneiro MO, Hartl C, Poplin R, Del Angel G, Levy-Moonshine A, Jordan T, Shakir K, Roazen D, Thibault J, Banks E, Garimella KV, Altshuler D, Gabriel S, DePristo MA. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinformatics. 2013;43:11.10.1-11.10.33. doi: 10.1002/0471250953.bi1110s43.</citation>
    <PMID>25431634</PMID>
  </reference>
  <reference>
    <citation>Vissers LE, Gilissen C, Veltman JA. Genetic studies in intellectual disability and related disorders. Nat Rev Genet. 2016 Jan;17(1):9-18. doi: 10.1038/nrg3999. Epub 2015 Oct 27. Review.</citation>
    <PMID>26503795</PMID>
  </reference>
  <reference>
    <citation>Zlotogora J, Shalev SA. The consequences of consanguinity on the rates of malformations and major medical conditions at birth and in early childhood in inbred populations. Am J Med Genet A. 2010 Aug;152A(8):2023-8. doi: 10.1002/ajmg.a.33537.</citation>
    <PMID>20635393</PMID>
  </reference>
  <results_reference>
    <citation>Cunniff C, Carmack JL, Kirby RS, Fiser DH. Contribution of heritable disorders to mortality in the pediatric intensive care unit. Pediatrics. 1995 May;95(5):678-81.</citation>
    <PMID>7724302</PMID>
  </results_reference>
  <results_reference>
    <citation>FitzPatrick DR, Skeoch CH, Tolmie JL. Genetic aspects of admissions to a paediatric intensive care unit. Arch Dis Child. 1991 May;66(5):639-41.</citation>
    <PMID>2039259</PMID>
  </results_reference>
  <results_reference>
    <citation>Gilissen C, Hoischen A, Brunner HG, Veltman JA. Unlocking Mendelian disease using exome sequencing. Genome Biol. 2011 Sep 14;12(9):228. doi: 10.1186/gb-2011-12-9-228. Review.</citation>
    <PMID>21920049</PMID>
  </results_reference>
  <results_reference>
    <citation>Hildreth A, Wigby K, Chowdhury S, Nahas S, Barea J, Ordonez P, Batalov S, Dimmock D, Kingsmore S; RCIGM Investigators. Rapid whole-genome sequencing identifies a novel homozygous NPC1 variant associated with Niemann-Pick type C1 disease in a 7-week-old male with cholestasis. Cold Spring Harb Mol Case Stud. 2017 Sep 1;3(5). pii: a001966. doi: 10.1101/mcs.a001966. Print 2017 Sep.</citation>
    <PMID>28550066</PMID>
  </results_reference>
  <results_reference>
    <citation>Kingsmore SF, Petrikin J, Willig LK, Guest E. Emergency medical genomes: a breakthrough application of precision medicine. Genome Med. 2015 Jul 30;7(1):82. doi: 10.1186/s13073-015-0201-z. eCollection 2015.</citation>
    <PMID>26229553</PMID>
  </results_reference>
  <results_reference>
    <citation>Lalani SR. Current Genetic Testing Tools in Neonatal Medicine. Pediatr Neonatol. 2017 Apr;58(2):111-121. doi: 10.1016/j.pedneo.2016.07.002. Epub 2016 Sep 28. Review.</citation>
    <PMID>28277305</PMID>
  </results_reference>
  <results_reference>
    <citation>Lee H, Deignan JL, Dorrani N, Strom SP, Kantarci S, Quintero-Rivera F, Das K, Toy T, Harry B, Yourshaw M, Fox M, Fogel BL, Martinez-Agosto JA, Wong DA, Chang VY, Shieh PB, Palmer CG, Dipple KM, Grody WW, Vilain E, Nelson SF. Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA. 2014 Nov 12;312(18):1880-7. doi: 10.1001/jama.2014.14604.</citation>
    <PMID>25326637</PMID>
  </results_reference>
  <results_reference>
    <citation>Petrikin JE, Willig LK, Smith LD, Kingsmore SF. Rapid whole genome sequencing and precision neonatology. Semin Perinatol. 2015 Dec;39(8):623-31. doi: 10.1053/j.semperi.2015.09.009. Epub 2015 Oct 29. Review.</citation>
    <PMID>26521050</PMID>
  </results_reference>
  <results_reference>
    <citation>Reardon S. Fast genetic sequencing saves newborn lives. Nature. 2014 Oct 2;514(7520):13-4. doi: 10.1038/514013a.</citation>
    <PMID>25279893</PMID>
  </results_reference>
  <results_reference>
    <citation>Saunders CJ, Miller NA, Soden SE, Dinwiddie DL, Noll A, Alnadi NA, Andraws N, Patterson ML, Krivohlavek LA, Fellis J, Humphray S, Saffrey P, Kingsbury Z, Weir JC, Betley J, Grocock RJ, Margulies EH, Farrow EG, Artman M, Safina NP, Petrikin JE, Hall KP, Kingsmore SF. Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. Sci Transl Med. 2012 Oct 3;4(154):154ra135. doi: 10.1126/scitranslmed.3004041.</citation>
    <PMID>23035047</PMID>
  </results_reference>
  <results_reference>
    <citation>Smith LD, Willig LK, Kingsmore SF. Whole-Exome Sequencing and Whole-Genome Sequencing in Critically Ill Neonates Suspected to Have Single-Gene Disorders. Cold Spring Harb Perspect Med. 2015 Dec 18;6(2):a023168. doi: 10.1101/cshperspect.a023168. Review.</citation>
    <PMID>26684335</PMID>
  </results_reference>
  <results_reference>
    <citation>Soden SE, Saunders CJ, Willig LK, Farrow EG, Smith LD, Petrikin JE, LePichon JB, Miller NA, Thiffault I, Dinwiddie DL, Twist G, Noll A, Heese BA, Zellmer L, Atherton AM, Abdelmoity AT, Safina N, Nyp SS, Zuccarelli B, Larson IA, Modrcin A, Herd S, Creed M, Ye Z, Yuan X, Brodsky RA, Kingsmore SF. Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders. Sci Transl Med. 2014 Dec 3;6(265):265ra168. doi: 10.1126/scitranslmed.3010076.</citation>
    <PMID>25473036</PMID>
  </results_reference>
  <results_reference>
    <citation>Thevenon J, Duffourd Y, Masurel-Paulet A, Lefebvre M, Feillet F, El Chehadeh-Djebbar S, St-Onge J, Steinmetz A, Huet F, Chouchane M, Darmency-Stamboul V, Callier P, Thauvin-Robinet C, Faivre L, Rivière JB. Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole-exome sequencing as a first-line diagnostic test. Clin Genet. 2016 Jun;89(6):700-7. doi: 10.1111/cge.12732. Epub 2016 Apr 26.</citation>
    <PMID>26757139</PMID>
  </results_reference>
  <results_reference>
    <citation>Willig LK, Petrikin JE, Smith LD, Saunders CJ, Thiffault I, Miller NA, Soden SE, Cakici JA, Herd SM, Twist G, Noll A, Creed M, Alba PM, Carpenter SL, Clements MA, Fischer RT, Hays JA, Kilbride H, McDonough RJ, Rosterman JL, Tsai SL, Zellmer L, Farrow EG, Kingsmore SF. Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings. Lancet Respir Med. 2015 May;3(5):377-87. doi: 10.1016/S2213-2600(15)00139-3. Epub 2015 Apr 27.</citation>
    <PMID>25937001</PMID>
  </results_reference>
  <results_reference>
    <citation>Yang Y, Muzny DM, Reid JG, Bainbridge MN, Willis A, Ward PA, Braxton A, Beuten J, Xia F, Niu Z, Hardison M, Person R, Bekheirnia MR, Leduc MS, Kirby A, Pham P, Scull J, Wang M, Ding Y, Plon SE, Lupski JR, Beaudet AL, Gibbs RA, Eng CM. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med. 2013 Oct 17;369(16):1502-11. doi: 10.1056/NEJMoa1306555. Epub 2013 Oct 2.</citation>
    <PMID>24088041</PMID>
  </results_reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>January 18, 2019</study_first_submitted>
  <study_first_submitted_qc>February 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2019</study_first_posted>
  <last_update_submitted>April 20, 2020</last_update_submitted>
  <last_update_submitted_qc>April 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fast trio exome</keyword>
  <keyword>Multiple congenital malformation</keyword>
  <keyword>Intensive care unit</keyword>
  <keyword>Neurological distress</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neurologic Manifestations</mesh_term>
    <mesh_term>Congenital Abnormalities</mesh_term>
    <mesh_term>Infant, Newborn, Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

